HAE — Haemonetics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual balance sheet for Haemonetics, fiscal year end - March 28th, USD millions except per share, conversion factor applied.

	2022 April 2nd	2023 April 1st	2024 March 30th	2025 March 29th	2026 March 28th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	259	284	179	307	245
Net Total Accounts Receivable
Net Total Receivables	159	179	207	203	217
Total Inventory
Prepaid Expenses
Total Current Assets	756	770	769	935	835
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	311	364	367	332	345
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	1,860	1,935	2,196	2,451	2,396
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	442	252	300	578	283
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	1,110	1,117	1,236	1,630	1,600
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	749	818	960	821	796
Total Liabilities & Shareholders' Equity	1,860	1,935	2,196	2,451	2,396
Total Common Shares Outstanding